Medical Cannabis and Cannabidiol: A New Harvest for Malawi

Overview

Journal Malawi Med J

Specialty General Medicine

Date 2022 Aug 22

PMID 35991815

Authors

Gama Bandawe

Affiliations

Soon will be listed here.

Abstract

In February 2020 parliament passed the Cannabis Regulation Bill (2020) which regulates the cultivation and production of industrial hemp and medical cannabis. The country will only fully benefit from this development if the medical and scientific community can take the lead in enabling the country to exploit the plant's potential to help address some of our economic and public health challenges. This special communication provides some basic information on cannabis and discusses its history and medical uses. Cannabidiol (CBD) has emerged as one of the most important cannabis-derived phytochemicals and has formed the basis for the growth of the medical cannabis industry. The scientific data on the mechanisms of the effects of CBD on the human neuroendocrine-immune network is reviewed and the first effective cannabis-based FDA-approved treatment for epilepsy discussed. Some clinical research that is being done on the antipsychotic and neuroprotective properties of CBD is also reviewed. A case is made for the potential of CBD as a neuroprotective adjunctive therapy for the prevention of neuropsychological sequelae associated with complicated malaria. The safety profile of CBD is reviewed and finally, the potential importance of the re-medicalization of cannabis-based therapies for the broader field of phytomedicine is pointed out.

Citing Articles

Opportunities, Challenges, and Scientific Progress in Hemp Crops.

Kaminski K, Hoeng J, Goffman F, Schlage W, Latino D Molecules. 2024; 29(10).

PMID: 38792258 PMC: 11124073. DOI: 10.3390/molecules29102397.

The potential for Ghana to become a leader in the African hemp industry.

Quansah Amissah R J Cannabis Res. 2023; 5(1):37.

PMID: 37899465 PMC: 10614304. DOI: 10.1186/s42238-023-00205-9.

References

Crawley J, Waruiru C, Mithwani S, Mwangi I, Watkins W, Ouma D . Effect of phenobarbital on seizure frequency and mortality in childhood cerebral malaria: a randomised, controlled intervention study. Lancet. 2000; 355(9205):701-6. DOI: 10.1016/S0140-6736(99)07148-2. View

Avraham Y, Grigoriadis N, Poutahidis T, Vorobiev L, Magen I, Ilan Y . Cannabidiol improves brain and liver function in a fulminant hepatic failure-induced model of hepatic encephalopathy in mice. Br J Pharmacol. 2010; 162(7):1650-8. PMC: 3057300. DOI: 10.1111/j.1476-5381.2010.01179.x. View

Pazos M, Cinquina V, Gomez A, Layunta R, Santos M, Fernandez-Ruiz J . Cannabidiol administration after hypoxia-ischemia to newborn rats reduces long-term brain injury and restores neurobehavioral function. Neuropharmacology. 2012; 63(5):776-83. DOI: 10.1016/j.neuropharm.2012.05.034. View

Schiavon A, Soares L, Bonato J, Milani H, Guimaraes F, de Oliveira R . Protective effects of cannabidiol against hippocampal cell death and cognitive impairment induced by bilateral common carotid artery occlusion in mice. Neurotox Res. 2014; 26(4):307-16. DOI: 10.1007/s12640-014-9457-0. View

ElSohly M, Radwan M, Gul W, Chandra S, Galal A . Phytochemistry of Cannabis sativa L. Prog Chem Org Nat Prod. 2017; 103:1-36. DOI: 10.1007/978-3-319-45541-9_1. View

Devinsky O, Cross J, Laux L, Marsh E, Miller I, Nabbout R . Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome. N Engl J Med. 2017; 376(21):2011-2020. DOI: 10.1056/NEJMoa1611618. View

Geffrey A, Pollack S, Bruno P, Thiele E . Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy. Epilepsia. 2015; 56(8):1246-51. DOI: 10.1111/epi.13060. View

Osborne A, Solowij N, Weston-Green K . A systematic review of the effect of cannabidiol on cognitive function: Relevance to schizophrenia. Neurosci Biobehav Rev. 2016; 72:310-324. DOI: 10.1016/j.neubiorev.2016.11.012. View

Gurley R, Aranow R, Katz M . Medicinal marijuana: a comprehensive review. J Psychoactive Drugs. 1998; 30(2):137-47. DOI: 10.1080/02791072.1998.10399683. View

10.

Di Marzo V . Endocannabinoids: synthesis and degradation. Rev Physiol Biochem Pharmacol. 2008; 160:1-24. DOI: 10.1007/112_0505. View

11.

Alger B, Kim J . Supply and demand for endocannabinoids. Trends Neurosci. 2011; 34(6):304-15. PMC: 3106144. DOI: 10.1016/j.tins.2011.03.003. View

12.

Yonelinas A . The hippocampus supports high-resolution binding in the service of perception, working memory and long-term memory. Behav Brain Res. 2013; 254:34-44. PMC: 3773061. DOI: 10.1016/j.bbr.2013.05.030. View

13.

Bechara R, Kelly A . Exercise improves object recognition memory and induces BDNF expression and cell proliferation in cognitively enriched rats. Behav Brain Res. 2013; 245:96-100. DOI: 10.1016/j.bbr.2013.02.018. View

14.

De Petrocellis L, Ligresti A, Moriello A, Allara M, Bisogno T, Petrosino S . Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes. Br J Pharmacol. 2010; 163(7):1479-94. PMC: 3165957. DOI: 10.1111/j.1476-5381.2010.01166.x. View

15.

Iffland K, Grotenhermen F . An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies. Cannabis Cannabinoid Res. 2017; 2(1):139-154. PMC: 5569602. DOI: 10.1089/can.2016.0034. View

16.

Magen I, Avraham Y, Ackerman Z, Vorobiev L, Mechoulam R, Berry E . Cannabidiol ameliorates cognitive and motor impairments in mice with bile duct ligation. J Hepatol. 2009; 51(3):528-34. DOI: 10.1016/j.jhep.2009.04.021. View

17.

Yuan P, Raz N . Prefrontal cortex and executive functions in healthy adults: a meta-analysis of structural neuroimaging studies. Neurosci Biobehav Rev. 2014; 42:180-92. PMC: 4011981. DOI: 10.1016/j.neubiorev.2014.02.005. View

18.

Iseger T, Bossong M . A systematic review of the antipsychotic properties of cannabidiol in humans. Schizophr Res. 2015; 162(1-3):153-61. DOI: 10.1016/j.schres.2015.01.033. View

19.

Gaitan A, Wood J, Zhang F, Makriyannis A, Lammi-Keefe C . Endocannabinoid Metabolome Characterization of Transitional and Mature Human Milk. Nutrients. 2018; 10(9). PMC: 6165354. DOI: 10.3390/nu10091294. View

20.

Petitet F, Jeantaud B, Reibaud M, Imperato A, Dubroeucq M . Complex pharmacology of natural cannabinoids: evidence for partial agonist activity of delta9-tetrahydrocannabinol and antagonist activity of cannabidiol on rat brain cannabinoid receptors. Life Sci. 1998; 63(1):PL1-6. DOI: 10.1016/s0024-3205(98)00238-0. View